DexCom Inc./ US2521311074 /
2024-06-07 7:57:20 AM | Chg. -2.6000 | Volume | Bid9:59:57 PM | Ask9:59:57 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.9600EUR | -2.39% | - Turnover: - |
107.1000Bid Size: 110 | 107.3200Ask Size: 110 | 42.63 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.